SecurAcath CASE STUDY Department/BU: Medical Territory: UK 34 SecurAcath Department/BU: Medical Territory: UK Owner: Amanda Sellick & Michele Rees-Williams Date: 12.09.17 CASE STUDY

Securement Device saving the NHS tens of thousands NICE Guidelines state: Annual savings across the NHS in England from using SecurAcath are estimated to be a minimum of £4.2 million. The challenge Our approach Results The challenge in Vascular access arena with regards to PICC lines and competitor products include: Need to change practice for Clinical Staff with a training and support given by Aquilant Medical. Converting all UK Trust using SecurAcath in PICC/MID/Central Lines and moving into Interventional Radiology and feeding tubes. Identifying the clinicians, understanding their issues and gaining acknowledgement of the accurate rates around dislodgment rates. Introducing the product, agreeing a defined patient group for the trial and training all areas of the hospital. Arranging clinical trials amongst Oncology & Haematology patients with agreement from Procurement and Infection Control teams. Setting up training with PICC Nurses Inserting PICC Lines through to follow up of care & maintenance. Other sessions of training on all Wards & Units plus community teams. With approximately a third of UK Trusts using SecurAcath. Successful implementation of the sales/training programme and improved customer relationship has enable Aquilant Medical to reach a wider segmented target audience. Developed a strong KOL base within the UK and leveraged expertise. Dramatically Reduced Catheter Dislodgement. 0 - 1.5% vs Adhesive Securement rates of 14 - 20% Increased sales revenue since 2016 rates of catheter migration and dislodgement rates of catheter-related infection, including catheter-related bloodstream infection, local infection or inflammation and thrombophlebitis number of unplanned catheter removals and reinsertions References:http://www.aquilantmedical.com/assets/aquilantmedical/Products/brochures/0000/SecurAcath_Brochure.pdf

Customer Testimonial - Lead Vascular Access Nurse at Broomfield Hospital Savings to be estimated to a minimum of £4.2 million Went from 20 chemotherapy patients to being rolled out across our whole service including midlines for both in and outpatients. Julie Godfrey, Lead Vascular Access Nurse at Broomfield Hospital “SecurAcath has been a very successful change in our practice. Our line migrations have been reduced to almost negligible. The device is easy to insert, works well for the patient providing confidence in line security for both patient and clinician during the life of the line & making care and maintenance much safer & easier. SecurAcath has reduced complications and subsequent costs, inconvenience and risks associated with repeated procedures for the patient. The support from ‘Aquilant’ Medical has been second to none & the resources provided for teaching and for patients are excellent.” Air handling unit pulls in air from inside the warehouse and filters it removing dust and also pulls in fresh air from outside to pump fresh air into the warehouse. NICE endorsed Developed a range of UK & International KOLs to support the educational program. Saved us time, money and improved our patient and end user experience. CASE STUDY